280 related articles for article (PubMed ID: 38669419)
1. Main mechanisms and clinical implications of alterations in energy expenditure state among patients with pheochromocytoma and paraganglioma: A review.
Yang Y; Zhou T; Zhao X; Cai Y; Xu Y; Gang X; Wang G
Medicine (Baltimore); 2024 Apr; 103(17):e37916. PubMed ID: 38669419
[TBL] [Abstract][Full Text] [Related]
2. Genotype-Dependent Brown Adipose Tissue Activation in Patients With Pheochromocytoma and Paraganglioma.
Puar T; van Berkel A; Gotthardt M; Havekes B; Hermus AR; Lenders JW; van Marken Lichtenbelt WD; Xu Y; Brans B; Timmers HJ
J Clin Endocrinol Metab; 2016 Jan; 101(1):224-32. PubMed ID: 26574955
[TBL] [Abstract][Full Text] [Related]
3. Hypermetabolism and Substrate Utilization Rates in Pheochromocytoma and Functional Paraganglioma.
Petrák O; Haluzíková D; Klímová J; Zítek M; Holaj R; Michalský D; Novák K; Petráková-Doležalová R; Kvasnička J; Nguyen TMPN; Krátká Z; Matoulek M; Widimský J; Zelinka T
Biomedicines; 2022 Aug; 10(8):. PubMed ID: 36009527
[TBL] [Abstract][Full Text] [Related]
4. [Clinical profile of pheochromocytoma and paraganglioma with normal plasma free metanephrines].
Liu L; Tian J; Wu K; Gao Y; Zhang Z; Zhang JQ; Guo XH
Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Aug; 52(4):614-620. PubMed ID: 32773788
[TBL] [Abstract][Full Text] [Related]
5. Plasma Metabolome Profiling for the Diagnosis of Catecholamine Producing Tumors.
März J; Kurlbaum M; Roche-Lancaster O; Deutschbein T; Peitzsch M; Prehn C; Weismann D; Robledo M; Adamski J; Fassnacht M; Kunz M; Kroiss M
Front Endocrinol (Lausanne); 2021; 12():722656. PubMed ID: 34557163
[TBL] [Abstract][Full Text] [Related]
6. Changes in energy metabolism in pheochromocytoma.
Petrák O; Haluzíková D; Kaválková P; Štrauch B; Rosa J; Holaj R; Brabcová Vránková A; Michalsky D; Haluzík M; Zelinka T; Widimsky J
J Clin Endocrinol Metab; 2013 Apr; 98(4):1651-8. PubMed ID: 23436923
[TBL] [Abstract][Full Text] [Related]
7. Pheochromocytoma and Paraganglioma Patients With Poor Survival Often Show Brown Adipose Tissue Activation.
Abdul Sater Z; Jha A; Hamimi A; Mandl A; Hartley IR; Gubbi S; Patel M; Gonzales M; Taïeb D; Civelek AC; Gharib AM; Auh S; O'Mara AE; Pacak K; Cypess AM
J Clin Endocrinol Metab; 2020 Apr; 105(4):1176-85. PubMed ID: 31903484
[TBL] [Abstract][Full Text] [Related]
8. Pheochromocytoma/paraganglioma-associated cardiomyopathy.
Szatko A; Glinicki P; Gietka-Czernel M
Front Endocrinol (Lausanne); 2023; 14():1204851. PubMed ID: 37522121
[TBL] [Abstract][Full Text] [Related]
9. Genotype-specific abnormalities in mitochondrial function associate with distinct profiles of energy metabolism and catecholamine content in pheochromocytoma and paraganglioma.
Rao JU; Engelke UF; Rodenburg RJ; Wevers RA; Pacak K; Eisenhofer G; Qin N; Kusters B; Goudswaard AG; Lenders JW; Hermus AR; Mensenkamp AR; Kunst HP; Sweep FC; Timmers HJ
Clin Cancer Res; 2013 Jul; 19(14):3787-95. PubMed ID: 23723300
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and Safety of High-Specific-Activity
Pryma DA; Chin BB; Noto RB; Dillon JS; Perkins S; Solnes L; Kostakoglu L; Serafini AN; Pampaloni MH; Jensen J; Armor T; Lin T; White T; Stambler N; Apfel S; DiPippo VA; Mahmood S; Wong V; Jimenez C
J Nucl Med; 2019 May; 60(5):623-630. PubMed ID: 30291194
[TBL] [Abstract][Full Text] [Related]
11. Pathophysiology and Management of Glycemic Alterations before and after Surgery for Pheochromocytoma and Paraganglioma.
Lopez C; Bima C; Bollati M; Bioletto F; Procopio M; Arata S; Candela DG; Beccuti G; Ghigo E; Maccario M; Parasiliti-Caprino M
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982228
[TBL] [Abstract][Full Text] [Related]
12. Detection of brown adipose tissue by
Santhanam P; Treglia G; Ahima RS
J Clin Hypertens (Greenwich); 2018 Mar; 20(3):615. PubMed ID: 29443440
[No Abstract] [Full Text] [Related]
13. [The clinical significance of the determination of catecholamine catabolites in neoplasms].
Käser H; Schweisguth O; Sellei K; Spengler GA
Helv Med Acta; 1963 Nov; 30(4):628-39. PubMed ID: 5878832
[No Abstract] [Full Text] [Related]
14. Metabolic Alterations in Patients with Pheochromocytoma.
Erlic Z; Beuschlein F
Exp Clin Endocrinol Diabetes; 2019 Feb; 127(2-03):129-136. PubMed ID: 30011405
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis of endocrine disease: Biochemical diagnosis of phaeochromocytoma and paraganglioma.
van Berkel A; Lenders JW; Timmers HJ
Eur J Endocrinol; 2014 Mar; 170(3):R109-19. PubMed ID: 24347425
[TBL] [Abstract][Full Text] [Related]
16. 15 YEARS OF PARAGANGLIOMA: Metabolism and pheochromocytoma/paraganglioma.
Mannelli M; Rapizzi E; Fucci R; Canu L; Ercolino T; Luconi M; Young WF
Endocr Relat Cancer; 2015 Aug; 22(4):T83-90. PubMed ID: 26113605
[TBL] [Abstract][Full Text] [Related]
17. [Biological diagnosis of pheochromocytomas and paragangliomas].
d'Herbomez M; Rouaix N; Bauters C; Wémeau JL
Presse Med; 2009 Jun; 38(6):927-34. PubMed ID: 19135846
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of laboratory data of 155 patients with pheochromocytoma-paraganglioma syndrome diagnosed during the past 20 years].
Balog B; Tőke J; Róna K; Szücs N; Igaz P; Pusztai P; Sármán B; Gláz E; Kiss R; Patócs A; Rácz K; Tóth M
Orv Hetil; 2015 Apr; 156(16):626-35. PubMed ID: 25864138
[TBL] [Abstract][Full Text] [Related]
19. Catecholamine metabolism in paraganglioma and pheochromocytoma: similar tumors in different sites?
Grouzmann E; Tschopp O; Triponez F; Matter M; Bilz S; Brändle M; Drechser T; Sigrist S; Zulewski H; Henzen C; Fischli S; Abid K
PLoS One; 2015; 10(5):e0125426. PubMed ID: 25946206
[TBL] [Abstract][Full Text] [Related]
20. Pheochromocytoma/Paraganglioma: A Poster Child for Cancer Metabolism.
Tevosian SG; Ghayee HK
J Clin Endocrinol Metab; 2018 May; 103(5):1779-1789. PubMed ID: 29409060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
